In Vitro Models in BiocompatibilityAssessment for Biomedical-Grade Chitosan Derivatives in Wound Management

One of the ultimate goals of wound healing research is to find effective healing techniques that utilize the regeneration of similar tissues. This involves the modification of various wound dressing biomaterials for proper wound management. The biopolymer chitosan (b-1,4-D-glucosamine) has natural b...

Full description

Bibliographic Details
Main Authors: Lim Chin Keong, Ahmad Sukari Halim
Format: Article
Language:English
Published: MDPI AG 2009-03-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:http://www.mdpi.com/1422-0067/10/3/1300/
_version_ 1811259825535844352
author Lim Chin Keong
Ahmad Sukari Halim
author_facet Lim Chin Keong
Ahmad Sukari Halim
author_sort Lim Chin Keong
collection DOAJ
description One of the ultimate goals of wound healing research is to find effective healing techniques that utilize the regeneration of similar tissues. This involves the modification of various wound dressing biomaterials for proper wound management. The biopolymer chitosan (b-1,4-D-glucosamine) has natural biocompatibility and biodegradability that render it suitable for wound management. By definition, a biocompatible biomaterial does not have toxic or injurious effects on biological systems. Chemical and physical modifications of chitosan influence its biocompatibility and biodegradability to an uncertain degree. Hence, the modified biomedical-grade of chitosan derivatives should be pre-examined in vitro in order to produce high-quality, biocompatible dressings. In vitro toxicity examinations are more favorable than those performed in vivo, as the results are more reproducible and predictive. In this paper, basic in vitro tools were used to evaluate cellular and molecular responses with regard to the biocompatibility of biomedical-grade chitosan. Three paramount experimental parameters of biocompatibility in vitro namely cytocompatibility, genotoxicity and skin pro-inflammatory cytokine expression, were generally reviewed for biomedical-grade chitosan as wound dressing.
first_indexed 2024-04-12T18:38:24Z
format Article
id doaj.art-0f9fb4537fc24a5cacebb9e68afa2e57
institution Directory Open Access Journal
issn 1422-0067
language English
last_indexed 2024-04-12T18:38:24Z
publishDate 2009-03-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-0f9fb4537fc24a5cacebb9e68afa2e572022-12-22T03:20:52ZengMDPI AGInternational Journal of Molecular Sciences1422-00672009-03-011031300131310.3390/ijms10031300In Vitro Models in BiocompatibilityAssessment for Biomedical-Grade Chitosan Derivatives in Wound ManagementLim Chin KeongAhmad Sukari HalimOne of the ultimate goals of wound healing research is to find effective healing techniques that utilize the regeneration of similar tissues. This involves the modification of various wound dressing biomaterials for proper wound management. The biopolymer chitosan (b-1,4-D-glucosamine) has natural biocompatibility and biodegradability that render it suitable for wound management. By definition, a biocompatible biomaterial does not have toxic or injurious effects on biological systems. Chemical and physical modifications of chitosan influence its biocompatibility and biodegradability to an uncertain degree. Hence, the modified biomedical-grade of chitosan derivatives should be pre-examined in vitro in order to produce high-quality, biocompatible dressings. In vitro toxicity examinations are more favorable than those performed in vivo, as the results are more reproducible and predictive. In this paper, basic in vitro tools were used to evaluate cellular and molecular responses with regard to the biocompatibility of biomedical-grade chitosan. Three paramount experimental parameters of biocompatibility in vitro namely cytocompatibility, genotoxicity and skin pro-inflammatory cytokine expression, were generally reviewed for biomedical-grade chitosan as wound dressing.http://www.mdpi.com/1422-0067/10/3/1300/biopolymerchitosanbiocompatibilitybiomedical-grade chitosanin vitro toxicity examinationscytocompatibilitygenotoxicityskin pro-inflammatory cytokine expression
spellingShingle Lim Chin Keong
Ahmad Sukari Halim
In Vitro Models in BiocompatibilityAssessment for Biomedical-Grade Chitosan Derivatives in Wound Management
International Journal of Molecular Sciences
biopolymer
chitosan
biocompatibility
biomedical-grade chitosan
in vitro toxicity examinations
cytocompatibility
genotoxicity
skin pro-inflammatory cytokine expression
title In Vitro Models in BiocompatibilityAssessment for Biomedical-Grade Chitosan Derivatives in Wound Management
title_full In Vitro Models in BiocompatibilityAssessment for Biomedical-Grade Chitosan Derivatives in Wound Management
title_fullStr In Vitro Models in BiocompatibilityAssessment for Biomedical-Grade Chitosan Derivatives in Wound Management
title_full_unstemmed In Vitro Models in BiocompatibilityAssessment for Biomedical-Grade Chitosan Derivatives in Wound Management
title_short In Vitro Models in BiocompatibilityAssessment for Biomedical-Grade Chitosan Derivatives in Wound Management
title_sort in vitro models in biocompatibilityassessment for biomedical grade chitosan derivatives in wound management
topic biopolymer
chitosan
biocompatibility
biomedical-grade chitosan
in vitro toxicity examinations
cytocompatibility
genotoxicity
skin pro-inflammatory cytokine expression
url http://www.mdpi.com/1422-0067/10/3/1300/
work_keys_str_mv AT limchinkeong invitromodelsinbiocompatibilityassessmentforbiomedicalgradechitosanderivativesinwoundmanagement
AT ahmadsukarihalim invitromodelsinbiocompatibilityassessmentforbiomedicalgradechitosanderivativesinwoundmanagement